New Zealand markets closed

Swiftmerge Acquisition Corp. (IVCPW)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.0513-0.0092 (-15.21%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.0605
Open0.0513
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.0513 - 0.0513
52-week range0.0513 - 0.0513
Volume1,500
Avg. volumeN/A
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    HDL Therapeutics to Go Public in Merger with Swiftmerge Acquisition Corp.

    NEW YORK & VERO BEACH, Fla., August 11, 2023--HDL Therapeutics, Inc. ("HDL Therapeutics"), a privately held commercial stage biotech company with an FDA-approved cardiovascular therapy the Plasma Delipidation System (PDS-2™ System) for reducing coronary atheroma in patients with homozygous familial hypercholesterolemia (HoFH), has signed a definitive merger agreement with Swiftmerge Acquisition Corp. (NASDAQ: IVCP) ("Swiftmerge"), a special purpose acquisition company with a disruptive consumer